cobas 5800 is a new compact addition to the Roche (RHHBY) molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such ...
The cobas® Liat System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less Utilizing Nobel prize winning polymerase chain reaction (PCR) ...
(RTTNews) - The U.S. Food and Drug Administration has granted 510(k) clearance for the cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and cobas 8800 Systems, Swiss ...
Roche announced the launch of three molecular PCR diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens: influenza A, influenza B and respiratory syncytial ...
COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, by Roche Molecular Diagnostics The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche ...
PLEASANTON, Calif., Feb. 23, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion of the COVID-19 PCR portfolio to the cobas Ⓡ 5800 System, a recently launched ...
The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.
The US Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) waiver for the Roche's cobas Strep A test for use on the cobas Liat System. It is the first CLIA ...
TROY, Mont.--(BUSINESS WIRE)-- In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not ...
The US Food and Drug Administration released a letter on Friday warning clinical laboratory and point-of-care staff, as well as healthcare providers, that false positive results for Roche's test for ...
PLEASANTON, Calif., July 13 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has obtained a worldwide co-exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback